Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Soc Trans ; 32(Pt 6): 1130-2, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15506988

ABSTRACT

IgA1 (immunoglobulin A1) antibodies are the first line of defence against microbial pathogens such as Neisseria meningitidis and Haemophilus influenzae. However, these bacteria secrete a site-specific protease that is capable of cleaving human IgA1 and interacting with other host components. The IgA proteases are released by the type V secretion pathway, which involves translocation through two membranes and an autolytic, post-translational processing step. Results reported recently throw light on the type V secretion pathway and on the roles of the multifunctional IgA protease. The IgA1 protease-recognition sequence is present within the IgA1 hinge region as well as in the variable sequence connecting the IgA1 protease to its translocator domain. Recent results suggest that neisserial IgA1 proteases are capable of cleaving substrates lacking the classical recognition sequence. This review will cover recent advances in the IgA protease field.


Subject(s)
Serine Endopeptidases/chemistry , Serine Endopeptidases/metabolism , Anti-Infective Agents/chemistry , Models, Molecular , Protein Conformation , Protein Structure, Secondary
2.
Biochem J ; 357(Pt 3): 779-85, 2001 Aug 01.
Article in English | MEDLINE | ID: mdl-11463348

ABSTRACT

A new method for continuous biopanning has been developed. We have combined the power of affinity chromatography with the fecundity of bacteria in a unique process that mimics clonal selection. Mixed populations of bacteria were applied to a fermenter containing the immobilized ligand of interest. Bacteria retained in this affinity fermenter were allowed to grow under continuous washout conditions, such that weakly bound organisms were selectively lost. Those initially rare founder bacteria expressing a receptor for the immobilized ligand (R+ve) were thus enriched and amplified simultaneously. From an initial culture containing 1 x 10(10) R-ve cells spiked with fewer than 30 R+ve bacteria (<1 in 10(8)), final ratios of R+ve/R-ve bacteria as high as 1 in 12 were observed, representing an enrichment factor of 55 million-fold. This technology has considerable potential for rapid screening of bacterial surface-display libraries and in facilitating directed-evolution studies.


Subject(s)
Bacterial Outer Membrane Proteins/analysis , Bacterial Proteins , Chromatography, Affinity/methods , Escherichia coli/chemistry , Membrane Glycoproteins/analysis , Fermentation , Ligands , Peptide Library
3.
FASEB J ; 13(2): 331-7, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9973321

ABSTRACT

Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae possess the ability to cleave human IgA1 antibodies, and all successfully colonize and occasionally invade the human upper respiratory tract. N. meningitidis invades the bloodstream after a period of nasopharyngeal colonization. We directly compared levels of IgA1 protease activity in strains (n=52) derived from the cerebrospinal fluid or blood of patients with meningococcal disease with strains of N. meningitidis obtained from asymptomatic carriers (n=25). IgA1 protease activity was determined by a sensitive semiquantitative ELISA assay. Levels of IgA1 protease activity were significantly higher (P<0.0001) in strains associated with invasive meningococcal disease (98% with detectable activity, mean = 580 mU) than with those obtained from asymptomatic carriers (76% with detectable activity, mean = 280 mU). Despite marked variation in enzyme activity, almost all strains (96%) possessed the gene for IgA1 protease. Given the panmictic population structure of the bacterial isolates investigated, these data, obtained from two groups infected with N. meningitidis, but with markedly different clinical outcomes, provide the first quantitative evidence that IgA1 protease activity is a virulence determinant that contributes to the pathogenic phenotype, and suggest IgA1 protease as a potential target for prophylaxis.


Subject(s)
Meningitis, Meningococcal/microbiology , Neisseria meningitidis/enzymology , Neisseria meningitidis/pathogenicity , Serine Endopeptidases/blood , Serine Endopeptidases/cerebrospinal fluid , Biomarkers , Humans , Immunoglobulin A/blood , Meningitis, Meningococcal/blood , Meningitis, Meningococcal/cerebrospinal fluid , Neisseria meningitidis/isolation & purification , Virulence
4.
FEMS Microbiol Lett ; 108(1): 1-5, 1993 Mar 15.
Article in English | MEDLINE | ID: mdl-8472917

ABSTRACT

Nine different bacterial strains that utilise phenylacetic acid as the only carbon and energy source were isolated from samples of different geographical origin. The isolates were characterised taxonomically and physiologically. Evidence is presented that in all the isolates as well as in four previously isolated control strains with the ability to utilize phenylacetic acid, the enzyme phenylacetate-CoA ligase is specifically induced during growth on phenylacetic acid. The Michaelis constant (Km) in one Pseudomonas strain was sufficiently low (-1 mM) to suggest that the enzyme may have a role in phenylacetic acid metabolism.


Subject(s)
Bacteria/metabolism , Coenzyme A Ligases/biosynthesis , Acinetobacter/growth & development , Acinetobacter/metabolism , Alcaligenes/growth & development , Alcaligenes/metabolism , Bacteria/growth & development , Enzyme Induction , Escherichia coli/growth & development , Escherichia coli/metabolism , Kinetics , Phenylacetates/metabolism , Providencia/growth & development , Providencia/metabolism , Pseudomonas/growth & development , Pseudomonas/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...